ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Highly Sensitized Patients Transplanted via the Eurotransplant Acceptable Mismatch Program Have Excellent Long-Term Graft Survival.

S. Heidt, M. Witvliet, G. Haasnoot, F. Claas.

Eurotransplant Reference Laboratory, Leiden University Medical Center, Leiden, Netherlands.

Meeting: 2016 American Transplant Congress

Abstract number: A104

Keywords: HLA matching, Kidney transplantation, Panel reactive antibodies, Sensitization

Session Information

Date: Saturday, June 11, 2016

Session Name: Poster Session A: Kidney Desensitization

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Related Abstracts
  • Accumulation of Highly Sensitized Patients in a KPD Registry.
  • Impact of New Kidney Allocation System on Transplant Rates for Highly Sensitized Patients-Center Specific Study.

The Eurotransplant Acceptable Mismatch (AM) program has been initiated 25 years ago in order to enhance transplantation of highly sensitized renal transplant candidates. Instead of avoiding unacceptable antigens, this program makes use of acceptable antigens, defined as antigens to which the patient has never formed antibodies, to predict a negative CDC crossmatch. Through addition of these acceptable antigens to the patient's own HLA phenotype, and mandatory shipment of a compatible organ to AM recipients, increased rates of transplantation of highly sensitized patients have been achieved. Here, we present long-term graft survival data on patients transplanted through the AM program.

We analyzed 10-year death censored graft survival of patients transplanted through regular allocation (Eurotransplant Kidney Allocation System: ET-KAS) and through the AM program. ET-KAS patients were subdivided according to the level of sensitization (0-5% PRA: non-sensitized, 6-85% PRA: sensitized, and >85% PRA: highly sensitized). Graft survival was compared to (highly sensitized) patients transplanted through the AM program.

AM patients had better 10-year graft survival compared to their highly sensitized counterparts transplanted through ET-KAS (P<0.001), whereas no statistically significant difference between AM patients and sensitized ET-KAS patients was observed. Non-sensitized patients had the best graft survival (P= 0.03). As the majority of AM patients received a re-transplant (71.2%) compared to a minority (14.9%) of ET-KAS patients (P<0.000001), we subsequently analyzed the 10-year graft survival of all re-transplant recipients. In this analysis, we found that AM patients had far superior graft survival compared to highly-sensitized ET-KAS patients (P=0.000003), and similar graft survival compared to sensitized (P= 0.05) and non-sensitized patients (P= 1.00). Multivariate analysis on all highly sensitized patients showed that the following parameters were independently affecting long-term graft survival: the number of HLA-A, -B, -DR mismatches, transplant period, donor sex and age, recipient age, as well as receiving a transplant through the AM program.

The AM program allows for increased rates of transplantation for highly sensitized patients while long-term graft survival of patients transplanted through the AM program is at least similar to that of patients transplanted through regular allocation.

CITATION INFORMATION: Heidt S, Witvliet M, Haasnoot G, Claas F. Highly Sensitized Patients Transplanted via the Eurotransplant Acceptable Mismatch Program Have Excellent Long-Term Graft Survival. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Heidt S, Witvliet M, Haasnoot G, Claas F. Highly Sensitized Patients Transplanted via the Eurotransplant Acceptable Mismatch Program Have Excellent Long-Term Graft Survival. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/highly-sensitized-patients-transplanted-via-the-eurotransplant-acceptable-mismatch-program-have-excellent-long-term-graft-survival/. Accessed January 19, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.